conduritol epoxide has been researched along with Parkinson Disease, Secondary in 1 studies
conduritol epoxide: conduritol C epoxide refers to the (epi & neo)-isomers; structure
conduritol epoxide : An epoxide resulting from the epoxidation of the double bond of a conduritol.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rocha, EM | 1 |
| Smith, GA | 1 |
| Park, E | 1 |
| Cao, H | 1 |
| Graham, AR | 1 |
| Brown, E | 1 |
| McLean, JR | 1 |
| Hayes, MA | 1 |
| Beagan, J | 1 |
| Izen, SC | 1 |
| Perez-Torres, E | 1 |
| Hallett, PJ | 1 |
| Isacson, O | 1 |
1 other study available for conduritol epoxide and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
Topics: alpha-Synuclein; Animals; Autophagy; Axonal Transport; Cerebral Cortex; Complement Activation; Compl | 2015 |